Advertisement

Table of Contents

November 01, 1982; Volume 22,Issue 3

You have access
Quantum chemical analysis of structure-activity relationships in nonsteroidal anti-inflammatory drugs.
E L Mehler, J Habicht and K Brune

Molecular Pharmacology November 1982, 22 (3) 525-528;
You have access
Initiation of in vitro lipid peroxidation by N-hydroxynorcocaine and norcocaine nitroxide.
G M Rosen, M W Kloss and E J Rauckman

Molecular Pharmacology November 1982, 22 (3) 529-531;
You have access
Characterization of alpha-adrenergic receptor subtypes in the rat renal cortex. Differential regulation of alpha 1- and alpha 2-adrenergic receptors by guanyl nucleotides and Na.
M D Snavely and P A Insel

Molecular Pharmacology November 1982, 22 (3) 532-546;
You have access
Identification and characterization of surface receptors for histamine in the human promyelocytic leukemia cell line HL-60. Comparison with human peripheral neutrophils.
C Gespach, F Saal, H Cost and J P Abita

Molecular Pharmacology November 1982, 22 (3) 547-553;
You have access
Characterization of nicotine binding in mouse brain and comparison with the binding of alpha-bungarotoxin and quinuclidinyl benzilate.
M J Marks and A C Collins

Molecular Pharmacology November 1982, 22 (3) 554-564;
You have access
Pumiliotoxin-C and synthetic analogues. A new class of nicotinic antagonists.
J E Warnick, P J Jessup, L E Overman, M E Eldefrawi, Y Nimit, J W Daly and E X Albuquerque

Molecular Pharmacology November 1982, 22 (3) 565-573;
You have access
Parallel observation of the occupancy of the alpha 2-adrenergic receptor in intact platelets and its ability to inhibit the adenylate cyclase.
D E Macfarlane and D C Stump

Molecular Pharmacology November 1982, 22 (3) 574-579;
You have access
Bidirectional collision coupling in the regulation of the adenylate cyclase. The allozyme hypothesis for receptor function.
D E Macfarlane

Molecular Pharmacology November 1982, 22 (3) 580-588;
You have access
Characterization of adenylate cyclase-coupled alpha 2-adrenergic receptors in rat renal cortex using [3H]yohimbine.
E A Woodcock and C I Johnston

Molecular Pharmacology November 1982, 22 (3) 589-594;
You have access
Selective effects of an essential sulfhydryl group on the activation of dopamine- and guanine nucleotide-sensitive adenylate cyclase.
E T Suen, P C Kwan and Y C Clement-Cormier

Molecular Pharmacology November 1982, 22 (3) 595-601;
You have access
Pharmacological characterization of histamine receptors mediating cyclic AMP accumulation in the mouse vas deferens. Sensitivity to H1 and H2 receptor agonists and antagonists.
M M Vohra and P K Rautanen

Molecular Pharmacology November 1982, 22 (3) 602-608;
You have access
Differences in the forskolin activation of adenylate cyclases in wild-type and variant lymphoma cells.
R B Clark, T J Goka, D A Green, R Barber and R W Butcher

Molecular Pharmacology November 1982, 22 (3) 609-613;
You have access
Modulation of insulin sensitivity by adenosine. Effects on glucose transport, lipid synthesis, and insulin receptors of the adipocyte.
H G Joost and H J Steinfelder

Molecular Pharmacology November 1982, 22 (3) 614-618;
You have access
Regulation of insulin receptors in frog erythrocytes by insulin and concanavalin A. Evidence for discrete classes of insulin binding sites.
R D Vale, A De Lean, R J Lefkowitz and J M Stadel

Molecular Pharmacology November 1982, 22 (3) 619-626;
You have access
Inhibition of binding of [3H]batrachotoxinin A 20-alpha-benzoate to sodium channels by the anticonvulsant drugs diphenylhydantoin and carbamazepine.
M Willow and W A Catterall

Molecular Pharmacology November 1982, 22 (3) 627-635;
You have access
Meproadifen reaction with the ionic channel of the acetylcholine receptor: potentiation of agonist-induced desensitization at the frog neuromuscular junction.
M A Maleque, C Souccar, J B Cohen and E X Albuquerque

Molecular Pharmacology November 1982, 22 (3) 636-647;
You have access
Etorphine binds to multiple opiate receptors of the caudate nucleus with equal affinity but with different kinetics.
A M Tolkovsky

Molecular Pharmacology November 1982, 22 (3) 648-656;
You have access
Structural characterization of beta-endorphin through the design, synthesis, and study of model peptides.
J W Taylor, R J Miller and E T Kaiser

Molecular Pharmacology November 1982, 22 (3) 657-666;
You have access
Conformational-energy studies of tetrapeptide opiates. Candidate active and inactive conformations.
G Loew, G Hashimoto, L Williamson, S Burt and W Anderson

Molecular Pharmacology November 1982, 22 (3) 667-677;
You have access
Inelastic electron tunneling spectroscopic study of interaction of acetylcholine and beta-methyl acetylcholine with alumina surface.
D Aslanian and S de Cheveigné

Molecular Pharmacology November 1982, 22 (3) 678-686;
You have access
Light-enhanced inhibition of ouabain binding to digitalis receptor in rat brain and guinea pig heart by the food dye erythrosine.
M Hnatowich and F S LaBella

Molecular Pharmacology November 1982, 22 (3) 687-692;
You have access
Formation of ADP-sensitive phosphorylated intermediate in the electric eel Na, K-ATPase preparation.
A Yoda and S Yoda

Molecular Pharmacology November 1982, 22 (3) 693-699;
You have access
Interaction between ouabain and the phosphorylated intermediate of Na,K-ATPase.
A Yoda and S Yoda

Molecular Pharmacology November 1982, 22 (3) 700-705;
You have access
Mechanism of inhibition of protein synthesis by morphine in rat brain and liver.
K C Retz and W J Steele

Molecular Pharmacology November 1982, 22 (3) 706-714;
You have access
Lack of Ca2+ ionophoretic activity of hypoglycemic sulfonylureas in excitable cells and isolated secretory granules.
E Gylfe and B Hellman

Molecular Pharmacology November 1982, 22 (3) 715-720;
You have access
Increased fluidity of a model membrane caused by tetrahydro-beta-carbolines.
P Peura, P Mackenzie, U Koivusaari and M Lang

Molecular Pharmacology November 1982, 22 (3) 721-724;
You have access
A theorem on de novo group contributions.
I Lukovitz

Molecular Pharmacology November 1982, 22 (3) 725-731;
You have access
Direct detection of the sulfur trioxide radical anion during the horseradish peroxidase-hydrogen peroxide oxidation of sulfite (aqueous sulfur dioxide).
C Mottley, T B Trice and R P Mason

Molecular Pharmacology November 1982, 22 (3) 732-737;
You have access
The relationship between the catalytic activities of rabbit pulmonary cytochrome P-450 isozymes and the lung-specific toxicity of the furan derivative, 4-ipomeanol.
C R Wolf, C N Statham, M G McMenamin, J R Bend, M R Boyd and R M Philpot

Molecular Pharmacology November 1982, 22 (3) 738-744;
You have access
Rat liver microsomal metabolism of propyl halides.
H Tachizawa, T L MacDonald and R A Neal

Molecular Pharmacology November 1982, 22 (3) 745-751;
You have access
Differences in the active-site region of tumor versus normal isozymes of mammalian ATP:L-methionine S-adenosyltransferase.
J R Sufrin and J B Lombardini

Molecular Pharmacology November 1982, 22 (3) 752-759;
You have access
Cytotoxicity of 5-fluoro-5'-O-nitro-2'-deoxyuridine, a new fluorinated pyrimidine derivative, in L1210 cultures.
D Roberts, P Franklin, G Odom, C Peck and T L Chwang

Molecular Pharmacology November 1982, 22 (3) 760-765;
You have access
Metabolic inhibition by a new antifolate, 2,4-diamino-6-(2,5-dimethoxybenzyl)-5-methyl-pyrido[2,3-d]pyrimidine (BW3O1U), an effective inhibitor of human lymphoid and dihydrofolate reductase-overproducing mouse cell lines.
W D Sedwick, M Hamrell, O E Brown and J Laszlo

Molecular Pharmacology November 1982, 22 (3) 766-770;
You have access
The selectivity of action of methotrexate in combination with 5-fluorouracil in xenografts of human colon adenocarcinomas.
J A Houghton, A J Tice and P J Houghton

Molecular Pharmacology November 1982, 22 (3) 771-778;
You have access
Quantitation of hepatic cytochrome P1-450 mRNA with the use of a cloned DNA probe. Effects of various P-450 inducers in C57BL/6N and DBA/2N mice.
R H Tukey, M Negishi and D W Nebert

Molecular Pharmacology November 1982, 22 (3) 779-786;
You have access
Immunochemical comparison and quantitation of microsomal flavin-containing monooxygenases in various hog, mouse, rat, rabbit, dog, and human tissues.
G A Dannan and F P Guengerich

Molecular Pharmacology November 1982, 22 (3) 787-794;
You have access
Endocrine regulation of cadmium-sensitive cytochrome P-450 in rat liver.
E M Lui, S R Slaughter, R M Philpot and G W Lucier

Molecular Pharmacology November 1982, 22 (3) 795-802;